Next Generation Orthopedic Technology Will Transform Global Care

Published
14 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$52.20
41.7% undervalued intrinsic discount
15 Aug
US$30.44
Loading
1Y
-31.3%
7D
5.9%

Author's Valuation

US$52.2

41.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on09 Aug 25
Fair value Decreased 7.28%

Enovis' price target has been revised lower, likely reflecting a modest decline in net profit margin despite slightly higher revenue growth expectations, resulting in a new consensus fair value of $53.40. What's in the News Enovis Corporation raised full-year 2025 revenue guidance to $2.245 billion–$2.275 billion, up from prior expectations of $2.220 billion–$2.250 billion.